A shadow market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Popularity Online
Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to individuals injecting substances of uncertain source.
Some experts said the demand for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Content Removal
Based on the social media company, the service has taken down problematic material and prohibited associated keywords and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Trading Activities
Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or injecting at home.
Within minutes of entering one group, a vendor posted contact information, where most purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Costs
Inside these groups, posts show dark colored packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to possibly serious health risks”.
